Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Drug Discovery Today. Technologies|September 13, 2018
CRISPR/Cas9 genome engineering in hematopoietic cellsDuran Sürün, Harald von Melchner, Frank SchnütgenMethods in Molecular Biology (Clifton, N.J.)|June 23, 2022
Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell LinesShady Sayed, Duran Sürün, Jovan Mircetic, et al.The FEBS Journal|May 27, 2014
Analysis of 5-lipoxygenase phosphorylation on molecular level by MALDI-MSStavroula Markoutsa, Duran Sürün, Michael Karas, et al.Frontiers in Immunology|March 31, 2025
A pooled CRISPR screen identifies the Tα2 enhancer element as a driver of <i>TRA</i> expression in a subset of mature human T lymphocytesPascal Y Schönberg, Ángela Muñoz-Ovalle, Maciej Paszkowski-Rogacz, et al.Molecular Therapy. Nucleic Acids|March 4, 2018
High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome EditingDuran Sürün, Joachim Schwäble, Ana Tomasovic, et al.Nucleic Acids Research|May 9, 2023
Discovery and characterization of novel Cre-type tyrosine site-specific recombinases for advanced genome engineeringMilica Jelicic, Lukas Theo Schmitt, Maciej Paszkowski-Rogacz, et al.Genome Biology|November 7, 2023
Quantification of evolved DNA-editing enzymes at scale with DEQSeqLukas Theo Schmitt, Aksana Schneider, Jonas Posorski, et al.Life Science Alliance|March 15, 2022
DNA methylation-independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteinsLi Ding, Lukas Theo Schmitt, Melanie Brux, et al.Cytotherapy|July 13, 2024
Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)-The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cellsRomy Kronstein-Wiedemann, Jessica Thiel, Duran Sürün, et al.Genes|May 10, 2020
Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime EditorsDuran Sürün, Aksana Schneider, Jovan Mircetic, et al.Pageof 3